Hospital
Rockwall Regional Hospital, LLC
Rockwall Regional Hospital, LLC was paid $976K by Medicaid between Jan 2020 and Nov 2024, across 47 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoROCKWALL REGIONAL HOSPITAL, LLC
ROCKWALL, TX 75032
ROCKWALL, TX 75032
33aNPI1629138029assigned 12/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$976K
24GClaims24,881
24DCodes billed47
24AFirst – last monthJan 2020 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#58 of 109
Median peer was paid$1.15M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 334 | $2K | |
| 2021 | 6,037 | $266K | |
| 2022 | 10,250 | $356K | |
| 2023 | 5,708 | $262K | |
| 2024incomplete | 2,552 | $90K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 2,230 | 2,089 | $367K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 2,919 | 2,786 | $167K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 632 | 583 | $151K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.8% | 1,044 | 1,010 | $86K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 855 | 822 | $29K |
| 80053 | Comprehensive metabolic panel | 2.5% | 2,325 | 2,019 | $24K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 977 | 876 | $24K |
| 71045 | Radiologic examination, chest; single view | 2.2% | 1,008 | 926 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 2,960 | 2,436 | $19K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 77 | 73 | $18K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.7% | 1,358 | 1,313 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 355 | 339 | $10K |
35 more codes
| 84484 | <1% | 868 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 77 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 60 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 561 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 52 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 400 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 42 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 609 | $2K |
| 87634 | <1% | 44 | $2K | |
| 81025 | <1% | 316 | $2K | |
| 81001 | <1% | 951 | $2K | |
| 83880 | <1% | 106 | $2K | |
| 83690 | <1% | 492 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 242 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 28 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 59 | $967.68 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $827.09 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 14 | $696.85 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 562 | $463.63 |
| 84703 | <1% | 64 | $449.16 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 86 | $415.30 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 249 | $348.92 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 50 | $318.11 |
| 83605 | <1% | 58 | $270.83 | |
| 81003 | <1% | 155 | $248.72 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 145 | $189.75 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 51 | $182.84 |
| 84702 | <1% | 15 | $113.76 | |
| 83735 | <1% | 26 | $85.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,338 | $82.48 |
| 85379 | <1% | 13 | $54.20 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 24 | $46.70 |
| 85610 | <1% | 16 | $18.67 | |
| 86901 | <1% | 14 | $15.06 | |
| A9270 | Non-covered item or service | 0% | 341 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLINSCOTT, JASON (PRESIDENT)